---
document_datetime: 2023-09-21 22:02:29
document_pages: 5
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/zoledronic-acid-actavis-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
document_name: zoledronic-acid-actavis-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 9.4403102
conversion_datetime: 2025-12-26 18:50:59.290033
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Zoledronic acid Actavis

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                  | Opinion/ Notification 1 issued on   | Commission Decision IssuedÂ² / amended on   | Product Information affected3   | Summary   |
|----------------------|----------------------------------------------------------------------------------------|-------------------------------------|--------------------------------------------|---------------------------------|-----------|
| IG/1612              | A.1 - Administrative change - Change in the name and/oraddressoftheMAH                 | 31/05/2023                          |                                            | SmPC, Labelling and PL          |           |
| N/0025               | Minorchangeinlabellingorpackageleafletnot connected with theSPC(Art.61.3 Notification) | 05/11/2021                          |                                            | PL                              |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| IA/0024   | B.II.f.1.e-Stability of FP-Change toan approved                                                                                                                                                                                   | 09/07/2021   | n/a        |                                  | stability protocol   |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----------------------------------|----------------------|
|           | C.I.2.a-Changein theSPC,LabellingorPLofa  generic/hybrid/biosimilar products following assessment of the same change for the reference product-Implementationof change(s)forwhichNO new additional dataisrequired tobesubmittedby | 09/09/2020   | 22/09/2021 | SmPC, Annex II, Labelling and PL | IB/0023 the MAH      |
| N/0022    | Minor changeinlabelling orpackageleafletnot connected with the SPC(Art.61.3 Notification)                                                                                                                                         | 06/01/2020   | 22/09/2021 | PL                               |                      |
|           | A.4-Administrativechange-Changeinthename and/or address of a manufacturer or an ASMF holder orsupplieroftheAS,startingmaterial,reagentor intermediateused inthemanufactureof theASor manufacturerofanovelexcipient                | 08/08/2019   | n/a        |                                  | IA/0021              |
|           | B.II.b.3.a-Change in the manufacturingprocess of thefinishedorintermediateproduct-Minorchange inthemanufacturingprocess                                                                                                           | 07/05/2019   | n/a        |                                  | IA/0020              |
|           | Minorchangeinlabellingorpackageleafletnot connectedwiththeSPC(Art.61.3Notification)                                                                                                                                               | 05/10/2018   | 22/09/2021 | PL                               | N/0019               |
|           | C.I.2.a-Change in the SPC,Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product-Implementation of change(s)for whichNO                                        | 03/10/2017   | 28/09/2018 | SmPC and PL                      | IB/0018              |

<div style=\"page-break-after: always\"></div>

|         | new additional data is required tobesubmitted by                                                                                                                                                                                                                                                                              |            |            |                        | the MAH         |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-----------------|
| R/0017  | Renewal of themarketing authorisation.                                                                                                                                                                                                                                                                                        | 13/10/2016 | 08/12/2016 | SmPC, Labelling and PL |                 |
|         | C.I.2.a-Changein theSPC,Labelling orPL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required tobe submitted by                                                                                 | 07/07/2016 | 08/12/2016 | SmPC, Labelling and PL | IB/0016 the MAH |
| IA/0015 | B.II.d.1.a-Change in the specification parameters and/or limits of thefinishedproduct-Tightening of specification limits                                                                                                                                                                                                      | 16/05/2016 | n/a        |                        |                 |
| IA/0014 | B.I.b.2.a-Change in test procedure forAS or startingmaterial/reagent/intermediate-Minor changesto anapprovedtestprocedure                                                                                                                                                                                                     | 14/01/2016 | n/a        |                        |                 |
|         | Thiswas an applicationfor a group of variations. B.I.b.1.b -Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent-Tightening of specification limits B.I.b.2.a-Change in test procedure forAS or startingmaterial/reagent/intermediate-Minor changestoanapprovedtestprocedure | 16/12/2015 | n/a        |                        | IA/0012/G       |

<div style=\"page-break-after: always\"></div>

|         | C.I.z-Changes(Safety/Efficacy)of Human and Veterinary Medicinal Products-Othervariation                                                                                                                                                         | 14/12/2015   | 08/12/2016   | SmPC and PL           | IAIN/0013   |
|---------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|-----------------------|-------------|
|         | C.I.2.a -Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessmentofthesamechangeforthereference product - Implementation of change(s) for which NO new additional dataisrequired tobesubmittedby the MAH | 09/10/2015   | 10/12/2015   | SmPC, Annex II and PL | IB/0011     |
| IB/0009 | C.I.11.z-Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation,including the RMP-Othervariation                                                                                                         | 17/06/2015   | n/a          |                       |             |
|         | C.I.8.a-Introduction of orchanges to a summary of Pharmacovigilancesystem-ChangesinQPPV (includingcontactdetails)and/or changesinthe PSMF location                                                                                              | 12/06/2015   | n/a          |                       | IAIN/0010   |
|         | A.7-Administrativechange-Deletion of manufacturingsites                                                                                                                                                                                         | 23/04/2015   | n/a          |                       | IA/0007     |
| IB/0006 | C.I.2.a-Changein theSPC,Labelling orPL of a generic/hybrid/biosimilar products following assessmentofthesamechangeforthereference product-Implementationof change(s)forwhichNO newadditional dataisrequiredtobesubmittedby the MAH              | 08/01/2015   | 10/12/2015   | SmPC and PL           |             |
|         | Minor changeinlabellingorpackageleafletnot connected with the SPC (Art. 61.3 Notification)                                                                                                                                                      | 13/08/2014   | 10/12/2015   | PL                    | N/0005      |

<div style=\"page-break-after: always\"></div>

| IB/0004   | C.I.2.a-Change in the SPC,Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product-Implementation of change(s)for whichNO newadditional dataisrequired tobesubmittedby the MAH   | 15/01/2014   | 20/02/2014   | SmPC andPL            |         |
|-----------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|--------------|-----------------------|---------|
| IB/0003   | B.II.f.1.b.1-Stability of FP-Extension of the shelf lifeofthefinishedproduct-Aspackagedforsale (supportedbyreal time data)                                                                                                                        | 16/08/2013   | 20/02/2014   | SmPC                  |         |
| IB/0002   | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessmentofthesamechangeforthereference product - Implementation of change(s) for which NO newadditionaldataaresubmittedbytheMAH                  | 16/07/2013   | 20/02/2014   | SmPC, Annex II and PL |         |
|           | C.I.2.a-Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessmentofthesamechangeforthereference product - Implementation of change(s) for which NO new additional data aresubmittedby theMAH                | 10/01/2013   | 20/02/2014   | SmPC and PL           | IB/0001 |